Labroots is pleased to announce the 11th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This 3 day event will take place on October 3-5, 2023....
We invite you to attend this virtual educational workshop. Our speakers will discuss patient-centered strategies to optimize patient safety in cardiac surgery, through a comprehensive bleedi...
Labroots invites you to the 6th Annual Event in the CRISPR Virtual Event Series! This event will continue the conversation on the abilities of CRISPR-based editing, and much more....
Labroots is pleased to announce the 14th Annual Event in the Clinical Diagnostics & Research Virtual Event Series to be held on November 9th, 2023 packed with featured speakers....
Labroots and the Drug Discovery planning committee are pleased to announce its 7th Annual Event in the Drug Discovery & Development Virtual Event Series . Labroots will host this online-...
Labroots is excited to present the 12th Annual Event in the Neuroscience Virtual Event Series , to be broadcasted live on March 6th, 2024. This distinguished, online-only, event is free to a...
Welcome to the 8th Annual Event in the Laboratory Automation Virtual Event Series ; a free virtual conference for professionals interested in the most recent technologies for today’s l...
Labroots is pleased to announce the 6th Annual Event in the Bioprocessing Virtual Event Series ! Join us for this free, one-day event on April 3, 2024 as we discuss upstream and downstream p...
Labroots is pleased to announce the 7th Annual Event in the 2023 Cannabis Sciences Virtual Event Series . Labroots will host the event on April 17, 2024. The Cannabis Sciences planning commi...
LabRoots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event taking place on May 1, 2024. Immuno-Oncology is considered by some to be one of the most promising area...
Labroots is excited to announce our 12th Annual Event in the Genetics Week Virtual Event Series held on May 14-16, 2024! Genetics Week Virtual Event Series 2024 will offer a multi-day conten...
Labroots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 10 th An...
Labroots and the Cell Biology Planning Committee are pleased to announce the 8th Annual Event in the Cell Biology Virtual Event Series 2024 , providing an opportunity to discuss recent disco...
Current clinical methods used to identify epithelial ovarian cancer are often too late – when the cancer is at an advanced stage, leaving the patient with limited therapeutic options....
Organoids continue to gain traction in drug discovery efforts as they offer a more biologically relevant disease model than traditional approaches. But they aren't without challenges. Jo...
In this session we will help you gain an understanding of a Class II BSC's role in the rapidly growing cell and gene therapy market. We will cover......
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
In June 2022, the ICH released the first draft of its harmonized global Drug Interaction Studies Guideline (M12). The guideline is the result of several meetings of the Expert Working Group...
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...
Embark on an enlightening journey through the intricate landscape of loop-mediated isothermal amplification (LAMP) technology. Unveil the ingenious mechanism of rapid DNA amplification under...